147 related articles for article (PubMed ID: 32513225)
1. Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
Mohamed MMA; El-Shimy IA; Hadi MA
Crit Care; 2020 Jun; 24(1):311. PubMed ID: 32513225
[No Abstract] [Full Text] [Related]
2. Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.
Courcelle R; Gaudry S; Serck N; Blonz G; Lascarrou JB; Grimaldi D;
Crit Care; 2020 Jul; 24(1):446. PubMed ID: 32684169
[No Abstract] [Full Text] [Related]
3. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Bendjelid K; Giraud R; Von Düring S
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
[No Abstract] [Full Text] [Related]
4. Fibrinolytic therapy in patients with COVID-19 and acute respiratory distress syndrome: Is this a feasible approach?
Savioli F; Rocha L; Góis A; Nakano LC
J Trauma Acute Care Surg; 2020 Dec; 89(6):e187-e188. PubMed ID: 32868539
[No Abstract] [Full Text] [Related]
5. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
Cadegiani FA
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
[No Abstract] [Full Text] [Related]
6. Vitamin D Deficiency and ARDS after SARS-CoV-2 Infection.
Faul JL; Kerley CP; Love B; O'Neill E; Cody C; Tormey W; Hutchinson K; Cormican LJ; Burke CM
Ir Med J; 2020 May; 113(5):84. PubMed ID: 32603575
[No Abstract] [Full Text] [Related]
7. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
[No Abstract] [Full Text] [Related]
8. Considerations for Statin Therapy in Patients with COVID-19.
Dashti-Khavidaki S; Khalili H
Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
[No Abstract] [Full Text] [Related]
9. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
Caocci G; La Nasa G
Ann Hematol; 2020 Jul; 99(7):1675-1676. PubMed ID: 32405693
[No Abstract] [Full Text] [Related]
10. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome.
Garcia B; Cousin N; Bourel C; Jourdain M; Poissy J; Duburcq T;
Crit Care; 2020 Jul; 24(1):428. PubMed ID: 32665007
[No Abstract] [Full Text] [Related]
11. Usefulness and safety of a dedicated team to prone patients with severe ARDS due to COVID-19.
Kimmoun A; Levy B; Chenuel B;
Crit Care; 2020 Aug; 24(1):509. PubMed ID: 32811555
[No Abstract] [Full Text] [Related]
12. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
[TBL] [Abstract][Full Text] [Related]
13. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
Soto M; diZerega G; Rodgers KE
J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
[TBL] [Abstract][Full Text] [Related]
14. Physiological Changes During Prone Positioning in COVID-19 Acute Respiratory Distress Syndrome.
Lee RM; Tan GP; Puah SH; Ling LM; Choy CY; Chotirmall SH; Abisheganaden J; See JJ; Tan HL; Wong YL
Ann Acad Med Singap; 2020 Jul; 49(7):509-513. PubMed ID: 33000116
[No Abstract] [Full Text] [Related]
15. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock.
Wang H; Das S; Wieruszewski PM; Taji J; Bartlett B; Azad N; Chowdhury A; Kolar GJ; Jain N; Subla MR; Khan SA
Chest; 2020 Aug; 158(2):e55-e58. PubMed ID: 32335068
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.
Matucci-Cerinic M; Bruni C; Allanore Y; Clementi M; Dagna L; Damjanov NS; de Paulis A; Denton CP; Distler O; Fox D; Furst DE; Khanna D; Krieg T; Kuwana M; Lee EB; Li M; Pillai S; Wang Y; Zeng X; Taliani G
Ann Rheum Dis; 2020 Jun; 79(6):724-726. PubMed ID: 32349982
[TBL] [Abstract][Full Text] [Related]
17. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome.
Chiscano-Camón L; Ruiz-Rodriguez JC; Ruiz-Sanmartin A; Roca O; Ferrer R
Crit Care; 2020 Aug; 24(1):522. PubMed ID: 32847620
[No Abstract] [Full Text] [Related]
18. Subphenotyping Acute Respiratory Distress Syndrome in Patients with COVID-19: Consequences for Ventilator Management.
Bos LDJ; Paulus F; Vlaar APJ; Beenen LFM; Schultz MJ
Ann Am Thorac Soc; 2020 Sep; 17(9):1161-1163. PubMed ID: 32396457
[No Abstract] [Full Text] [Related]
19. The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.
Kloc M; Ghobrial RM
Mult Scler Relat Disord; 2020 Oct; 45():102437. PubMed ID: 32763844
[TBL] [Abstract][Full Text] [Related]
20. What is the role of rheumatologists in the era of COVID-19?
Marotto D; Sarzi-Puttini P
Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
[No Abstract] [Full Text] [Related]
[Next] [New Search]